Fraunhofer Biotech-Enhanced Plant Growth to be Commercialized by Delaware Research Center
IP2Revenues LLC (IP2R), an Intellectual Property Commercialization & Licensing company, has signed a contract with the Fraunhofer USA Center for Molecular Biotechnology (FhCMB) to expedite commercialization of a proprietary technology developed by Fraunhofer. "We're very excited about thi ... more
